BIND Therapeutics

unknown
unknown
Stage
1
Investors

About

BIND Therapeutics is a biotechnology company focused on developing targeted nanoparticle therapies for the treatment of cancer and other serious diseases.

Explore BIND Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.